December 2002
Volume 43, Issue 13
Free
ARVO Annual Meeting Abstract  |   December 2002
Retinal Endothelial Occludin Phosphorylation Increases with Diabetes and VEGF Activation and is Downstream of Protein Kinase C
Author Affiliations & Notes
  • DA Antonetti
    Departments of Cellular & Molecular Physiology and Ophthalmology Penn State College of Medicine Hershey PA
  • EB Wolpert
    Departments of Cellular & Molecular Physiology and Ophthalmology Penn State College of Medicine Hershey PA
  • TW GardnerPenn State Retina Research Group
    Departments of Cellular & Molecular Physiology and Ophthalmology Penn State College of Medicine Hershey PA
  • Footnotes
    Commercial Relationships   D.A. Antonetti, None; E.B. Wolpert, None; T.W. Gardner, Eli Lilly F. Grant Identification: NIH(EY12021), JDRF, PA Lions, ADA
Investigative Ophthalmology & Visual Science December 2002, Vol.43, 2970. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      DA Antonetti, EB Wolpert, TW GardnerPenn State Retina Research Group; Retinal Endothelial Occludin Phosphorylation Increases with Diabetes and VEGF Activation and is Downstream of Protein Kinase C . Invest. Ophthalmol. Vis. Sci. 2002;43(13):2970.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: Diabetic retinopathy is characterized by increased vascular permeability causing retinal edema. At least part of the increase in permeability can be attributed to elevated VEGF within the eye. We have previously shown that VEGF induces phosphorylation of the tight junction protein occludin in retinal endothelial cells in vivo and in primary bovine retinal endothelial cell (BREC) culture. This phosphorylation can be detected as a gel shift in the migration of occludin on Western blots. In the present study we determined whether diabetes increases retinal occludin phosphorylation. In addition, mounting evidence indicates both protein kinase C (PKC) and nitric oxide synthase (NOS) contribute to vascular permeability induced by VEGF. Therefore, specific PKC and NOS inhibitors were tested to determine the contribution of these enzymes in VEGF stimulated occludin phosphorylation. Methods: Animals were made diabetic with streptozotocin and diabetes was confirmed by monitoring blood glucose. Retinas were removed and homogenized in an SDS/Triton X-100/deoxycholate extraction buffer. Occludin phosphorylation was quantified by gel shift on Western blots and the ratio of hyperphosphorylated to hypophosphorylated occludin was determined. Results: Occludin phosphorylation increased after 1 month (p<0.005) and 3 months (p<0.05) of diabetes. Furthermore, VEGF induced a similar increase in occludin phosphorylation in BREC. The NOS inhibitor L-NMMA blocked occludin phosphorylation in response to VEGF but had no effect on occludin phosphorylation in control samples. In addition, a PKC inhibitor blocked occludin phosphorylation at both 600 nM (broad spectrum PKC inhibition) and at 30 nM (PKC ß specific inhibition). Conclusion: These studies reveal that diabetes and VEGF induce occludin phosphorylation through an NOS and PKC ß dependent pathway. PKC ß regulation of occludin phosphorylation may induce vascular permeability.

Keywords: 388 diabetic retinopathy • 339 cell adhesions/cell junctions • 423 growth factors/growth factor receptors 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×